Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain (SALIENT)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a Phase I/II, double‐blind, parallel‐group, randomized, placebo‐controlled multi‐centre trial in 180 patients randomized 1:1:1 to receive the IMP (Dexamethasone acetate microspheres for extended‐release injectable micro‐suspension, SX600 at 12.5 mg or 25.0 mg) or Placebo (0.9% Sodium Chloride for Injection, BP) via transforaminal epidural injection to the lumbosacral epidural space.
Epistemonikos ID: fd788e0057b89349d2fb9b8bd41151895b3aa10a
First added on: May 22, 2024